Diagnostic difficulties of primary hemochromatosis in a patient with posthemorrhagic anemia


Cite item

Full Text

Abstract

Hereditary hemochromatosis (HH) is a disease with an autosomal recessive hereditary type, stipulated by the genetic defect that leads to a high intestinal absorption of iron and primary accumulation in the parenchymal cells of the liver and other organs. This is the most common hereditary disease among White population, the frequency is about 1 case per 250 people. The prevalence of HH is inhomogeneous, people from countries in Northern Europe, especially Scandinavian, are more susceptible to this disease. Mutations of the HFE gene account for approximately 90% of HH cases. In HH excess iron deposits mainly in the cytoplasm of parenchymal cells of various organs and tissues: in the liver, pancreas, endocrine glands, skin and joints. The clinical picture of HH is characterized by the classical triad development: cirrhosis of the liver, diabetes mellitus (DM) and hyperpigmentation. HH may also manifest itself as various endocrinopathies (hypofunction of hypophysis, adrenal glands, thyroid gland, arthropathy, cardiomyopathy). Diagnostics of HH is based on the determination of the iron metabolism values: serum iron, transferrin saturation, the amount of ferritin, the genetic tests, liver biopsy data are used to confirm the diagnosis. Despite the fact that HH is a well-studied disease, in some cases it is complicated to diagnose it. Developed posthemorrhagic anemia in a patient is one of such reasons when the iron metabolism test is not informative.

About the authors

V I Podzolkov

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

д.м.н., проф., зав. каф. факультетской терапии №2, директор клиники факультетской терапии № 2; ORCID: 0000-0002-0758-5609 Moscow, Russia

A E Pokrovskaya

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

к.м.н., доц. каф. факультетской терапии №2; тел.: +7(903)195-78-70; ORCID: 0000-0002-8875-9032 Moscow, Russia

T S Vargina

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

к.м.н., доц. каф. факультетской терапии №2; ORCID: 0000-0003-3076-4231 Moscow, Russia

K A Oganesyan

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)

зав. первым терапевтическим отд-нием Университетской клинической больницы №4; ORCID: 0000-0003-3580-7229 Moscow, Russia

References

  1. Ивашкин В.Т., Лапина Т.Л., редакторы. Гастроэнтерология: национальное руководство. М.: ГЭОТАР-Медиа; 2018. 464 с.
  2. Подымова С.Д. Болезни печени: Руководство. 4-е изд., перераб. и доп. М.: Медицина; 2005. 768 с.
  3. Barton J.C, Acton R.T. Diabetes in HFE Hemochromatosis. J Diabetes Res. 2017;2017:Article ID 9826930, 16 p. doi: 10.1155/2017/9826930
  4. Allen K.J, Gurrin L.C, Costantine C.C, et al. Iron - overload - related disease in HFE hereditary hemochromatosis. N Engl J Med. 2008;358(3):221-30.
  5. Шифф Ю.Р., Сорелл М.Ф., Мэддерей У.С.; пер. с англ. Под ред. Н.А. Мухина. Алкогольные, лекарственные, генетические и метаболические заболевания (Серия «Болезни печени по Шиффу»). Москва: ГЭОТАР-Медиа; 2011. 480 с.
  6. Савченко В.Г., редактор. Клинические рекомендации по диагностике и лечению вторичной перегрузки железом. М.; 2014. 17 с.
  7. Кляритская И.Л., Максимова Е.В. Клинические практические рекомендации по ведению пациентов с гемохроматозом. Крымский терапевтический журнал. 2012;(2):41-6.
  8. Barton J.C, Edwards C.Q, Phatak P.D, Britton R.S, Bacon B.R. Handbook of Iron Overload Disorders. Cambridge University Press. 2010. 368 p.
  9. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for HFE Hemochromatosis. J Hepatol. 2010. doi: 10.1016/j.jhep.2010.03.001
  10. Полунина Т.Е., Маев И.В. Диагностика синдрома перегрузки железом. Экспериментальная клиническая гастроэнтерология. 2010;(5):61-8.
  11. Bacon B.R, Adams P.C, Kowdley K.V, Powell L.W, Tavill A.S. Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(1):328-43. doi: 10.1002/hep.24330
  12. Muckenthaler M.U. How mutant HFE causes hereditary hemochromatosis. Blood. 2014;124:1212-3. doi: 10.1182/blood-2014-07-581744

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies